Search

everythinglearnresearchcommunity

for

Search:↓

Improving symptoms of male urinary problems may lower the risk of death.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Medications for PCOS don't seem to raise heart disease risk.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The SA-MS hydrogel is a promising material for improving wound healing and skin regeneration in diseases like diabetes and skin cancer.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Men with better urinary symptoms have a lower risk of death.

Hair loss may increase heart disease risk.

Shorter PSADT after prostate surgery is linked to higher risk of death.

DHT may increase the risk of heart disease and death in elderly men.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.